Cocrystal Pharma, Inc.
DE ˙ DB ˙ US19188J4094
0,88 € ↑0,01 (0,57%)
2026-06-04
PREZZO DELLE AZIONI
SecurityDE:8CC / Cocrystal Pharma, Inc.
InstitutionBlackRock, Inc.
Latest Disclosed Ownership73,746 shares
Latest Disclosed Value $ 74,483
BlackRock, Inc. ownership in 8CC / Cocrystal Pharma, Inc.

On May 13, 2026 - BlackRock, Inc. filed a 13F-HR form disclosing ownership of 73,746 shares of Cocrystal Pharma, Inc. (DE:8CC) valued at $62,684 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 12, 2026 disclosing 73,746 shares of Cocrystal Pharma, Inc.. This represents a change in shares of 0.00% during the quarter. The current value of the position is $64,896 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-13 2026-03-31 13F COCRYSTAL PHARMA COM NEW 19188J409 73,746 0 0.00 74 2.78 0.0000
2026-02-12 2025-12-31 13F COCRYSTAL PHARMA COM NEW 19188J409 73,746 0 0.00 72 -21.74 0.0000
2025-11-12 2025-09-30 13F COCRYSTAL PHARMA COM NEW 19188J409 73,746 0 0.00 92 -15.60 0.0000
2025-08-12 2025-06-30 13F COCRYSTAL PHARMA COM NEW 19188J409 73,746 0 0.00 110 4.81 0.0000
2025-05-02 2025-03-31 13F COCRYSTAL PHARMA COM NEW 19188J409 73,746 0 0.00 105 -29.73 0.0000
2025-02-07 2024-12-31 13F COCRYSTAL PHARMA COM NEW 19188J409 73,746 0 0.00 149 14.73 0.0000
2024-11-13 2024-09-30 13F COCRYSTAL PHARMA COM NEW 19188J409 73,746 0 0.00 130 -24.56 0.0000
2024-08-13 2024-06-30 13F COCRYSTAL PHARMA COM NEW 19188J409 73,746 0 0.00 172 66.02 0.0000
2024-05-10 2024-03-31 13F COCRYSTAL PHARMA COM NEW 19188J409 73,746 -317 -0.43 103 -18.90 0.0000
2024-02-13 2023-12-31 13F COCRYSTAL PHARMA COM NEW 19188J409 74,063 0 0.00 128 -7.97 0.0000
2023-11-13 2023-09-30 13F COCRYSTAL PHARMA COM NEW 19188J409 74,063 0 0.00 138 -22.03 0.0000
2023-08-11 2023-06-30 13F COCRYSTAL PHARMA COM NEW 19188J409 74,063 0 0.00 177 20.41 0.0000
2023-05-12 2023-03-31 13F COCRYSTAL PHARMA COM NEW 19188J409 74,063 0 0.00 147 2.08 0.0000
2023-02-13 2022-12-31 13F COCRYSTAL PHARMA COM NEW 19188J409 74,063 -814,679 -91.67 144 -44.40 0.0000
2022-11-14 2022-09-30 13F COCRYSTAL PHARMA COM 19188J300 888,742 0 0.00 259 -28.85 0.0000
2022-08-12 2022-06-30 13F COCRYSTAL PHARMA COM 19188J300 888,742 -222,266 -20.01 364 -40.43 0.0000
2022-05-12 2022-03-31 13F COCRYSTAL PHARMA COM 19188J300 1,111,008 -12,586 -1.12 611 -16.30 0.0000
2022-02-10 2021-12-31 13F COCRYSTAL PHARMA COM 19188J300 1,123,594 9,829 0.88 730 -37.55 0.0000
2021-11-09 2021-09-30 13F COCRYSTAL PHARMA COM 19188J300 1,113,765 -24,066 -2.12 1,169 -17.79 0.0000
2021-08-11 2021-06-30 13F COCRYSTAL PHARMA COM 19188J300 1,137,831 30,861 2.79 1,422 -7.60 0.0000
2021-05-07 2021-03-31 13F COCRYSTAL PHARMA COM 19188J300 1,106,970 0 0.00 1,539 2.26 0.0000
2021-02-05 2020-12-31 13F COCRYSTAL PHARMA COM 19188J300 1,106,970 1,106,970 0.00 1,505 -2.21 0.0000
2020-08-14 2020-06-30 13F COCRYSTAL PHARMA COM 19188J300 0 -36,483 -100.00 0 -100.00
2020-05-01 2020-03-31 13F COCRYSTAL PHARMA COM 19188J300 36,483 3,422 10.35 26 62.50 0.0000
2020-02-13 2019-12-31 13F COCRYSTAL PHARMA COM 19188J300 33,061 -348 -1.04 16 -76.47 0.0000
2019-11-08 2019-09-30 13F COCRYSTAL PHARMA COM PAR 19188J300 33,409 -1,914 -5.42 68 -18.07 0.0000
2019-08-22 2019-06-30 13F/A-1 COCRYSTAL PHARMA COM PAR 19188J300 35,323 4,685 15.29 83 -1.19 0.0000
2019-08-13 2019-06-30 13F COCRYSTAL PHARMA COM PAR 19188J300 35,323 4,685 83
2019-05-09 2019-03-31 13F COCRYSTAL PHARMA COM PAR 19188J300 30,638 -2,100 -6.41 84 -28.81 0.0000
2019-02-08 2018-12-31 13F COCRYSTAL PHARMA COM PAR 19188J300 32,738 -600 -1.80 118 42.17 0.0000
2018-11-09 2018-09-30 13F COCRYSTAL PHARMA COM PAR 19188J300 33,338 1,350 4.22 83 -29.06 0.0000
2018-08-09 2018-06-30 13F COCRYSTAL PHARMA COM PAR 19188J300 31,988 31,988 117 0.0000
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.